Key facts
- Notable investors include Innoangel Fund, Guangzhou Yuexiu Industrial Investment Fund Management, Chobe Capital, Dawu Venture Capital, Redhill Capital — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Yuanbo Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Yuanbo Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Yuanbo Medical
Developer of human and veterinary biological products designed for disease prevention and diagnosis. The company leverages its proprietary rod-shaped virus and insect cell antigen expression platforms, as well as a structural immunoadjuvant vaccine design platform, enabling the development of pet-related vaccines, therapeutic biological products, and pathogen testing, providing solutions that enhance animal health and safety.
- Sector
- Healthcare
- HQ
- Guangzhou, China
- Founded
- 2017
- Employees
- 7
- Ownership
- Privately Held (backing)
Yuanbo Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Yuanbo Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Yuanbo Medical in its N-PORT filings yet. We sweep new filings monthly.